Last reviewed · How we verify

NCT04424173

Combined Hormone Therapy, C-reactive Protein(CRP) Levels and Life Quality in Natural Menopause Women

Completed Last updated 29 June 2020
What this trial tests

trial in CRP in 45 participants. Completed in 30 August 2008.

Timeline
1 August 2007
Primary endpoint
1 August 2008
30 August 2008

Quick facts

Lead sponsorKaradeniz Technical University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment45
Start date1 August 2007
Primary completion1 August 2008
Estimated completion30 August 2008

Conditions studied

Sponsor

Karadeniz Technical University

Who can join

Adults 45 to 55, female only, with CRP or Menopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to assess the effect of low dose combined estradiol and norethindrone acetate hormone therapy on serum CRP levels and life quality in natural menopause women. 45 natural menopause women who admitted to Karadeniz Technical University, Faculty of Medicine, Department of Obstetrics and Gynaecology for 1 year and diagnosed as menopause and planned to have hormone therapy for menopausal symptoms involved in this study. The serum CRP levels and vasomotor symptoms scores graded according to Blatt-Kupperman Index and life quality scores according to Menopause-Specific Quality of Life Questionnaire (MENQOL) in Turkish were recorded before and after (3 months later) low dose hormone treatment (1 mg Estradiol and 0.5 mg Norethindrone acetate).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for CRP

Currently open trials in the same condition.

Other Karadeniz Technical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04424173.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing